Full-thickness retinal tear with vitreous hemorrhages and peripheral pigment ring. Most often caused by cholesterol embolism (Hollenhorst’s plaques); but other potential causes include fat or amniotic fluid emboli; compression from long bone fractures, hematomas, or intravenous drug abuse; as well as compression due to compression from long bone fractures, hematomas, or intravenous drug abuse.

The innovative method and device provide a means of accessing foveal function even when retina and/or fovea are impaired or nonfunctional.

Visual acuity

Visual Acuity (VA) is the measure of one’s ability to see objects at a standard distance. VA is determined by several factors, including how well light is focused onto the retina (primarily macula) and how efficiently neural elements interpret this information, producing images which are clear and sharp; in a healthy eye this results in images being crisp and clear – humans generally are considered having good vision by most standards, being capable of distinguishing details up to 20 feet away; birds, however, possess excellent eyesight with higher VA than humans (VA = higher VA than humans).

For visual acuity evaluations, doctors typically place a 10- or 20-foot Snellen chart at eye level and ask the patient to read letters from top to bottom across it. At each line on the chart, he or she must correctly identify at least one letter in order to pass that line; thereafter, physicians record your eye’s acuity level.

Physicians may also assess a patient’s near visual acuity by placing a Rosembaum chart for near vision at 14 inches or 35 centimeters away from them, so as to measure how close objects can be seen with only one eye; binocular vision generally being slightly superior.

Time taken for patient to see continuous lines is used as an assessment of cone’s recovery in light adapted retinas. To perform this test, patients are exposed to a moving light source at predetermined speed laterally across fovea with instructions to report first moment they see discontinuous line as opposed to continuous one; their physician then compares this interval against time interval in patients without compromised retinas.

Apart from the technical requirements of visual acuity testing, physicians must be able to communicate effectively with patients and understand the optotypes being tested. Patients must also cooperate and be willing to participate in examination – any failure on any one of these fronts could yield inaccurate results – for instance a sleepy or intoxicated patient may not respond correctly and give inaccurate readings.

Visual field

An unpleasant traditional method for evaluating visual fields in people with hypertensive retinopathy involves projecting a beam of light into each eye to evaluate their visual field. Unfortunately, this procedure requires them to look directly into a beam for an extended period of time while moving their eyes in an attempt to center it properly on their visual axis. As a result, inaccurate measurements of visual fields occur, leaving individuals unable to tell when their sensitivity has returned; our inventive device and method offers an alternative by which we can assess fovea function evaluation in patients with impaired visual acuity or diseased retina and/macula.

One embodiment of the invention comprises a device equipped with software for projecting and displaying circular images on retinal surfaces, with optical manipulation capabilities to make smaller or larger sizes as necessary. Furthermore, the device can also allow light source movement along any of its axes for evaluation of fovea function.

Light sources that move in a straight line across the center of an image will produce an afterimage on the retina and cause blinding, with its persistence depending on several factors: strength of light (stronger lights cause longer-lasting blinding effects), speed at which light is moving, function of fovea (a healthy fovea will experience shorter afterimages than one with diseased fovea), speed of moving light and health status of retina and fovea – these all play into play to affect blinding episodes.

To measure photoreceptor recovery time in a patient’s macula and retina, an inventive device and method first stimulates them with a strong pulse of light to bleach out an image area, followed by weaker standard sequential pulses of low energy that the patient recognizes; when this second weaker pulse becomes discernable to them indicates when retinal fatigue has subsided.

Retinal imaging

Retinal imaging uses high-resolution pictures of the inside of your eye to help VSP network doctors detect and manage eye and health conditions like diabetes, macular degeneration, glaucoma and cataracts. Retinal images provide a permanent record that allows comparison over time to detect even minute changes; using this information together with medical guidance they may assist both you and your physician in selecting effective treatments options for your specific condition.

The Moving Light Method measures your retina’s ability to process light rays that enter through your pupil. The test begins by shining a series of light pulses onto your retina that create an after image at regular intervals; following each pulse, your doctor will ask when you see either a circle or straight line appear in its aftermath – healthy retinas should show this quickly while those that cannot process incoming light rays may take longer for it to appear on its after image.

Retinal tears are full-thickness holes in the vitreous that may be horseshoe-shaped or circular in shape, typically found near the vitreous base or posterior border of lattice degeneration, that may lead to retinal detachment and lead to further complications like tobacco-dust signs (pigmented vitreous cells), retinal hole operculums and cystic retinal tufts.

This condition causes sudden vision loss due to abnormal blood flow to the retina. This often happens when large blood vessels leak or rupture, such as with retinal detachments. Symptoms include severe pain and sudden vision loss; treatment includes laser surgery that creates thousands of tiny burns near the macula to shrink abnormal blood vessels; additionally vitrectomy surgery may also help treat tears and detachments in retinas.

Hemorrhages between the retina and vitreous gel are an all-too-common result of both traumatic and non-traumatic retinal breaks, and frequently result from diabetic retinopathy. Other potential sources include choroidal neovascularization, hypertensive retinopathy, retinal vein occlusion or other sources of ocular hemorrhage.

Visual evoked potentials

Every time you see or touch something, your brain produces electrical impulses called evoked potentials. These extremely sensitive tests can help diagnose problems like optic neuritis and multiple sclerosis as well as assess nerve, spinal cord and brainstem function; tests are typically administered using visual stimuli such as checkerboard patterns or flashing lights as visual stimuli.

Macular Edema occurs when retinal macula becomes swollen, making it harder for you to clearly perceive fine details. It may be caused by diabetes, glaucoma, age-related macular degeneration or retinal blood vessel obstruction and may slowly progress over weeks before suddenly losing vision requiring immediate medical care.

Visual Evoked Potentials (VEPs) are electrical responses to visual stimulation recorded in the occipital cortex of the brain and used as an aid in diagnosing blindness and measuring visual acuity, especially among babies or animals who cannot communicate verbally. VEPs also help assess vision quality over a longer timeframe in patients who have been blind for an extended period.

Visual evoked potentials are produced when exposed to certain visual stimuli, typically checkerboard patterns that move from black on white to white on black, which then provide an amplitude-peak measurement over time to assess response speed of visual systems and aid diagnosis of possible injuries that affect transmission of visual signals to the brain. This test can help detect whether or not an injury has impeded visual transmission to the brain, potentially giving early indications of brain dysfunction or damage.

Clinical trial results of suprachoroidal injections with RGX-314 demonstrated significant improvements in visual acuity for subjects diagnosed with hypertensive retinopathy with macular edema. Furthermore, retinal hemorrhages were reduced and choroidal neovascularization reduced significantly; however this result wasn’t as notable for diabetic retinopathy or macular degeneration patients due to more fibrovascular membranes and cystic macular edema present.